162 F. Supp. 3d 263
S.D.N.Y.2016Background
- GFI Group, a publicly traded inter-dealer broker and financial-software company, announced on July 30, 2014 a proposed merger with CME Group that would pay shareholders $4.55 per share.
- Jefferies had earlier advised GFI that a sale of GFI as a “sum of the parts” might fetch about $5.41/share (a ~64% premium to trading price); Jefferies recommended a buyer with an inter-dealer broker business for synergies.
- Michael Gooch (Executive Chairman and largest shareholder) favored a CME transaction and allegedly intended to use that deal to enable his investor group and insiders to buy GFI’s inter-dealer broker business privately at a discount.
- After GFI announced the CME deal (stock rose to approx. the merger price), BGC made a competing tender offer on September 9, 2014 and ultimately paid $6.10/share; shareholders rejected the CME transaction at a January 2015 vote.
- Gross (plaintiff) represents a class of shareholders who sold between July 30 and September 9, 2014, alleging Gooch and CEO Heffron made actionable misstatements (e.g., calling the CME merger a “singular and unique opportunity” to “optimize” value) that induced premature sales and concealed that superior offers existed.
- Defendants moved to dismiss the Second Amended Complaint, arguing the statements were non-actionable puffery and that Gross failed to plead loss causation; the court denied the motion.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Gooch's statements are actionable misrepresentations or non-actionable puffery | Gooch's statements that the CME deal was a "singular and unique opportunity" and would "optimize" value were material and false because Gooch knew superior bids were likely and intended to prefer insiders | Statements were generic corporate optimism (puffery) and thus not actionable under Rule 10b-5 | Court: Gooch's statements, as pleaded, are not obviously puffery; plausible that a reasonable investor would find them material and that Gooch knew them to be false; survives dismissal |
| Whether the complaint improperly pleads only state-law fiduciary claims (Santa Fe barrier) | Gross alleges affirmative misstatements in the securities context, not merely fiduciary breaches | Defendants say allegations are effectively fiduciary-breach claims and thus not a Rule 10b-5 claim | Court: Santa Fe does not apply because plaintiff pled affirmative misstatements under Rule 10b-5 |
| Whether Gross adequately pleaded loss causation (causal link between misstatements and economic harm) | Misstatements concealed that shares were undervalued and caused shareholders to sell before superior offers materialized; plaintiffs’ pleading burden is not heavy at motion to dismiss | Defendants contend plaintiff must show market price during the period was inaccurate due to defendants' statements rather than other factors | Court: Plaintiff pleaded loss causation adequately for pleading stage; if unclear, causation is generally not resolved on Rule 12(b)(6) |
| Pleading particularity and scienter under Rule 9(b) and PSLRA | Gross alleges specific statements, contextual facts (Jefferies advice, Gooch's admissions), and motive (insider benefit) supporting a strong inference of scienter | Defendants argue statements are vague and lack particularized facts showing intent to deceive | Court: Allegations suffice to survive dismissal as to Gooch's affirmative statements (scienter plausible at pleading stage) |
Key Cases Cited
- Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard for plausibility)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (pleading standard; plausibility and factual allegations)
- Virginia Bankshares, Inc. v. Sandberg, 501 U.S. 1083 (subjective opinion statements can be actionable)
- Rombach v. Chang, 355 F.3d 164 (puffery versus actionable misstatements in securities cases)
- Novak v. Kasaks, 216 F.3d 300 (statements not puffery when defendants knew contrary facts)
- TSC Indus., Inc. v. Northway, Inc., 426 U.S. 438 (materiality judged by the total mix of information)
- Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (loss causation pleading burden distinguished from proof)
- Loreley Financing (Jersey) No. 3 Ltd. v. Wells Fargo Secs., LLC, 797 F.3d 160 (loss causation and caution against deciding causation on Rule 12(b)(6))
- Lentell v. Merrill Lynch & Co., 396 F.3d 161 (transaction causation and loss causation concepts)
- Emergent Capital Inv. Mgmt., LLC v. Stonepath Grp., Inc., 343 F.3d 189 (loss causation proximate-cause framework)
- Santa Fe Indus. v. Green, 430 U.S. 462 (mere breach of fiduciary duty insufficient for Rule 10b-5 claim)